Hypertension: Beta-Blocker Pharmacokinetics
Beta-blocker pharmacokinetics comparison chart for hypertension.
Cardiovascular Disease
Combination Therapy of Bempedoic Acid, Ezetimibe Now Available as Adjunct to Statins
Nexlizet (bempedoic acid and ezetimibe; Esperion) is now available for use as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C.
Risk Factors Differ by First Cardiovascular Disease Manifestations in Type 1 Diabetes
Researchers found that risk factors differ between various first manifestations of cardiovascular disease in patients with type 1 diabetes.
Dyslipidemia Drug Indications
Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.
Hypertension Treatments: Oral CCBs
Oral calcium channel blockers (CCBs) for the treatment of hypertension including benzothiazepines, dihydropyridines, and diphenylalkylamines.
Hypertension Treatments: ACE Inhibitors
A comparative list of Angiotensin-Converting Enzyme (ACE) Inhibitors monotherapy and combination therapy for the treatment of hypertension.
Icosapent Ethyl Approved to Reduce Risk for CV Events in High-Risk Patients
Increased risk of atrial fibrillation and bleeding with Vascepa observed in cardiovascular outcomes trial.
Hypertension Treatments: Diuretics
A comparative list of loop, potassium-sparing, and thiazide-like diuretics monotherapy and combination therapy for the treatment of hypertension.
Combination Hypertension Treatments
A comparative list of combination antihypertensive medications.
Hypoglycemia Increases Risk for Sudden Cardiac Arrest in T2D
Hypoglycemic episodes may increase the risk for ventricular arrhythmia and sudden cardiac arrest among patients with type 2 diabetes.
-
Loading...
-
Loading...
Next post in News
